메뉴 건너뛰기




Volumn 118, Issue 2, 2011, Pages 280-288

Evaluation of the diagnostic accuracy of the risk of ovarian malignancy algorithm in women with a pelvic mass

Author keywords

[No Author keywords available]

Indexed keywords

CA 125 ANTIGEN; HUMAN EPIDIDYMIS PROTEIN 4;

EID: 79961056124     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: 10.1097/AOG.0b013e318224fce2     Document Type: Article
Times cited : (247)

References (27)
  • 1
    • 85026151773 scopus 로고    scopus 로고
    • Cancer facts & figures 2010.
    • Atlanta (GA), American Cancer Society
    • American Cancer Society. Cancer facts & figures 2010. Atlanta (GA): American Cancer Society; 2010; p. 1-62.
    • (2010) , pp. 1-62
  • 2
    • 77955549719 scopus 로고    scopus 로고
    • The National Cancer Database report on advanced-stage epithelial ovarian cancer: impact of hospital surgical case volume on overall survival and surgical treatment paradigm.
    • Bristow RE, Palis BE, Chi DS, Cliby WA. The National Cancer Database report on advanced-stage epithelial ovarian cancer: impact of hospital surgical case volume on overall survival and surgical treatment paradigm. Gynecol Oncol 2010;118:262-7.
    • (2010) Gynecol Oncol , vol.118 , pp. 262-7
    • Bristow, R.E.1    Palis, B.E.2    Chi, D.S.3    Cliby, W.A.4
  • 3
    • 32144437596 scopus 로고    scopus 로고
    • Effect of surgeon specialty on processes of care and outcomes for ovarian cancer patients.
    • Earle CC, Schrag D, Neville BA, Yabroff KR, Topor M, Fahey A, et al. Effect of surgeon specialty on processes of care and outcomes for ovarian cancer patients. J Natl Cancer Inst 2006;98:172-80.
    • (2006) J Natl Cancer Inst , vol.98 , pp. 172-80
    • Earle, C.C.1    Schrag, D.2    Neville, B.A.3    Yabroff, K.R.4    Topor, M.5    Fahey, A.6
  • 4
    • 27144439275 scopus 로고    scopus 로고
    • Who should operate on patients with ovarian cancer? An evidence-based review.
    • Giede KC, Kieser K, Dodge J, Rosen B. Who should operate on patients with ovarian cancer? An evidence-based review. Gynecol Oncol 2005;99:447-61.
    • (2005) Gynecol Oncol , vol.99 , pp. 447-61
    • Giede, K.C.1    Kieser, K.2    Dodge, J.3    Rosen, B.4
  • 6
    • 34248398805 scopus 로고    scopus 로고
    • The outcomes of ovarian cancer treatment are better when provided by gynecologic oncologists and in specialized hospitals: a systematic review.
    • Vernooij F, Heintz P, Witteveen E, van der Graaf Y. The outcomes of ovarian cancer treatment are better when provided by gynecologic oncologists and in specialized hospitals: a systematic review. Gynecol Oncol 2007;105:801-12.
    • (2007) Gynecol Oncol , vol.105 , pp. 801-12
    • Vernooij, F.1    Heintz, P.2    Witteveen, E.3    van der Graaf, Y.4
  • 7
    • 0034268483 scopus 로고    scopus 로고
    • Guidelines for referral to a gynecologic oncologist: rationale and benefits. The Society of Gynecologic Oncologists.
    • Guidelines for referral to a gynecologic oncologist: rationale and benefits. The Society of Gynecologic Oncologists. Gynecol Oncol 2000;78:S1-13.
    • (2000) Gynecol Oncol , vol.78
  • 8
    • 0036884015 scopus 로고    scopus 로고
    • The role of the generalist obstetrician-gynecologist in the early detection of ovarian cancer. ACOG Committee Opinion No. 280. American College of Obstetricians and Gynecologists.
    • The role of the generalist obstetrician-gynecologist in the early detection of ovarian cancer. ACOG Committee Opinion No. 280. American College of Obstetricians and Gynecologists. Obstet Gynecol 2002;100:1413-6.
    • (2002) Obstet Gynecol , vol.100 , pp. 1413-6
  • 10
  • 11
    • 33645328575 scopus 로고    scopus 로고
    • Improved short-term survival for advanced ovarian, tubal, and peritoneal cancer patients operated at teaching hospitals.
    • Paulsen T, Kjaerheim K, Kaern J, Tretli S, Trope C. Improved short-term survival for advanced ovarian, tubal, and peritoneal cancer patients operated at teaching hospitals. Int J Gynecol Cancer 2006;16(suppl 1):11-7.
    • (2006) Int J Gynecol Cancer , vol.16 , pp. 11-7
    • Paulsen, T.1    Kjaerheim, K.2    Kaern, J.3    Tretli, S.4    Trope, C.5
  • 13
    • 38649134531 scopus 로고    scopus 로고
    • The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass.
    • Moore RG, Brown AK, Miller MC, Skates S, Allard WJ, Verch T, et al. The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass. Gynecol Oncol 2008;108:402-8.
    • (2008) Gynecol Oncol , vol.108 , pp. 402-8
    • Moore, R.G.1    Brown, A.K.2    Miller, M.C.3    Skates, S.4    Allard, W.J.5    Verch, T.6
  • 14
    • 57649088474 scopus 로고    scopus 로고
    • A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass.
    • Moore RG, McMeekin DS, Brown AK, Disilvestro P, Miller MC, Allard WJ, et al. A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass. Gynecol Oncol 2009;112:40-6.
    • (2009) Gynecol Oncol , vol.112 , pp. 40-6
    • Moore, R.G.1    McMeekin, D.S.2    Brown, A.K.3    Disilvestro, P.4    Miller, M.C.5    Allard, W.J.6
  • 15
    • 77956342398 scopus 로고    scopus 로고
    • Comparison of a novel multiple marker assay vs the Risk of Malignancy Index for the prediction of epithelial ovarian cancer in patients with a pelvic mass.
    • Moore RG, Jabre-Raughley M, Brown AK, Robison KM, Miller MC, Allard WJ, et al. Comparison of a novel multiple marker assay vs the Risk of Malignancy Index for the prediction of epithelial ovarian cancer in patients with a pelvic mass. Am J Obstet Gynecol 2010;203:228.e1-6.
    • (2010) Am J Obstet Gynecol , vol.203 , pp. e1-e6
    • Moore, R.G.1    Jabre-Raughley, M.2    Brown, A.K.3    Robison, K.M.4    Miller, M.C.5    Allard, W.J.6
  • 16
    • 47249163215 scopus 로고    scopus 로고
    • Utility of a novel serum tumor biomarker HE4 in patients with endometrioid adenocarcinoma of the uterus.
    • Moore RG, Brown AK, Miller MC, Badgwell D, Lu Z, Allard WJ, et al. Utility of a novel serum tumor biomarker HE4 in patients with endometrioid adenocarcinoma of the uterus. Gynecol Oncol 2008;110:196-201.
    • (2008) Gynecol Oncol , vol.110 , pp. 196-201
    • Moore, R.G.1    Brown, A.K.2    Miller, M.C.3    Badgwell, D.4    Lu, Z.5    Allard, W.J.6
  • 17
    • 16844374909 scopus 로고    scopus 로고
    • Human epididymis protein 4 (HE4) is a secreted glycoprotein that is overexpressed by serous and endometrioid ovarian carcinomas.
    • Drapkin R, von Horsten HH, Lin Y, Mok SC, Crum CP, Welch WR, et al. Human epididymis protein 4 (HE4) is a secreted glycoprotein that is overexpressed by serous and endometrioid ovarian carcinomas. Cancer Res 2005;65:2162-9.
    • (2005) Cancer Res , vol.65 , pp. 2162-9
    • Drapkin, R.1    von Horsten, H.H.2    Lin, Y.3    Mok, S.C.4    Crum, C.P.5    Welch, W.R.6
  • 18
    • 33646886778 scopus 로고    scopus 로고
    • Comprehensive analysis of HE4 expression in normal and malignant human tissues.
    • Galgano MT, Hampton GM, Frierson HF Jr. Comprehensive analysis of HE4 expression in normal and malignant human tissues. Mod Pathol 2006;19:847-53.
    • (2006) Mod Pathol , vol.19 , pp. 847-53
    • Galgano, M.T.1    Hampton, G.M.2    Frierson, H.F.3
  • 19
    • 0033693082 scopus 로고    scopus 로고
    • Large-scale serial analysis of gene expression reveals genes differentially expressed in ovarian cancer.
    • Hough CD, Sherman-Baust CA, Pizer ES, Montz FJ, Im DD, Rosenshein NB, et al. Large-scale serial analysis of gene expression reveals genes differentially expressed in ovarian cancer. Cancer Res 2000;60:6281-7.
    • (2000) Cancer Res , vol.60 , pp. 6281-7
    • Hough, C.D.1    Sherman-Baust, C.A.2    Pizer, E.S.3    Montz, F.J.4    Im, D.D.5    Rosenshein, N.B.6
  • 20
    • 0035970050 scopus 로고    scopus 로고
    • Analysis of gene expression profiles in normal and neoplastic ovarian tissue samples identifies candidate molecular markers of epithelial ovarian cancer.
    • Welsh JB, Zarrinkar PP, Sapinoso LM, Kern SG, Behling CA, Monk BJ, et al. Analysis of gene expression profiles in normal and neoplastic ovarian tissue samples identifies candidate molecular markers of epithelial ovarian cancer. Proc Natl Acad Sci U S A 2001;98:1176-81.
    • (2001) Proc Natl Acad Sci U S A , vol.98 , pp. 1176-81
    • Welsh, J.B.1    Zarrinkar, P.P.2    Sapinoso, L.M.3    Kern, S.G.4    Behling, C.A.5    Monk, B.J.6
  • 22
    • 64949192073 scopus 로고    scopus 로고
    • Serum HE4 concentration differentiates malignant ovarian tumours from ovarian endometriotic cysts.
    • Huhtinen K, Suvitie P, Hiissa J, Junnila J, Huvila J, Kujari H, et al. Serum HE4 concentration differentiates malignant ovarian tumours from ovarian endometriotic cysts. Br J Cancer 2009;100:1315-9.
    • (2009) Br J Cancer , vol.100 , pp. 1315-9
    • Huhtinen, K.1    Suvitie, P.2    Hiissa, J.3    Junnila, J.4    Huvila, J.5    Kujari, H.6
  • 23
    • 77951976918 scopus 로고    scopus 로고
    • Serum biomarker panels for the discrimination of benign from malignant cases in patients with an adnexal mass.
    • Nolen B, Velikokhatnaya L, Marrangoni A, De GK, Lomakin A, Bast RC Jr, et al. Serum biomarker panels for the discrimination of benign from malignant cases in patients with an adnexal mass. Gynecol Oncol 2010;117:440-5.
    • (2010) Gynecol Oncol , vol.117 , pp. 440-5
    • Nolen, B.1    Velikokhatnaya, L.2    Marrangoni, A.3    De, G.K.4    Lomakin, A.5    Bast, R.C.6
  • 24
    • 0020559574 scopus 로고
    • A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer.
    • Bast RC Jr, Klug TL, St John E, Jenison E, Niloff JM, Lazarus H, et al. A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer. N Engl J Med 1983;309:883-7.
    • (1983) N Engl J Med , vol.309 , pp. 883-7
    • Bast, R.C.1    Klug, T.L.2    St John, E.3    Jenison, E.4    Niloff, J.M.5    Lazarus, H.6
  • 26
    • 79952784426 scopus 로고    scopus 로고
    • The ROMA (The Risk of Ovarian Malignancy Algorithm) for estimating the risk of epithelial ovarian cancer in women presenting with pelvic mass: is it really useful?
    • Montagnana M, Danese E, Ruzzenente O, Bresciani V, Nuzzo T, Gelati M, et al. The ROMA (The Risk of Ovarian Malignancy Algorithm) for estimating the risk of epithelial ovarian cancer in women presenting with pelvic mass: is it really useful? Clin Chem Lab Med 2011;49:521-5.
    • (2011) Clin Chem Lab Med , vol.49 , pp. 521-5
    • Montagnana, M.1    Danese, E.2    Ruzzenente, O.3    Bresciani, V.4    Nuzzo, T.5    Gelati, M.6
  • 27
    • 79952801158 scopus 로고    scopus 로고
    • Evaluation of the accuracy of serum human epididymis protein 4 in combination with CA125 for detecting ovarian cancer: a prospective case-control study in a Korean population.
    • Kim YM, Whang DH, Park J, Kim SH, Lee SW, Park HA, et al. Evaluation of the accuracy of serum human epididymis protein 4 in combination with CA125 for detecting ovarian cancer: a prospective case-control study in a Korean population. Clin Chem Lab Med 2011;49:527-34.
    • (2011) Clin Chem Lab Med , vol.49 , pp. 527-34
    • Kim, Y.M.1    Whang, D.H.2    Park, J.3    Kim, S.H.4    Lee, S.W.5    Park, H.A.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.